Aaron Balog

3.2k total citations
50 papers, 2.4k citations indexed

About

Aaron Balog is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Aaron Balog has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 22 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Aaron Balog's work include Cancer Treatment and Pharmacology (20 papers), Synthetic Organic Chemistry Methods (18 papers) and Advanced Synthetic Organic Chemistry (9 papers). Aaron Balog is often cited by papers focused on Cancer Treatment and Pharmacology (20 papers), Synthetic Organic Chemistry Methods (18 papers) and Advanced Synthetic Organic Chemistry (9 papers). Aaron Balog collaborates with scholars based in United States, Germany and Sweden. Aaron Balog's co-authors include Samuel J. Danishefsky, Dai‐Shi Su, Peter Bertinato, Dong‐Fang Meng, Ting‐Chao Chou, Erik J. Sorensen, Ted Kamenecka, Dennis P. Curran, Susan Band Horwitz and Kenneth A. Savin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Aaron Balog

50 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Balog United States 25 1.4k 1.1k 708 331 262 50 2.4k
Joaquı́n Pastor Spain 28 1.2k 0.9× 631 0.6× 2.0k 2.8× 242 0.7× 175 0.7× 66 3.2k
R. M. Borzilleri United States 27 1.1k 0.8× 826 0.7× 1.0k 1.4× 283 0.9× 210 0.8× 57 2.4k
Andrew J. Souers United States 30 685 0.5× 595 0.5× 2.0k 2.8× 100 0.3× 98 0.4× 79 3.1k
Karima Bettayeb France 18 397 0.3× 316 0.3× 731 1.0× 167 0.5× 158 0.6× 21 1.5k
Jen‐Shin Song Taiwan 22 346 0.3× 273 0.2× 625 0.9× 156 0.5× 82 0.3× 58 1.4k
Thelma S. Angeles United States 29 633 0.5× 616 0.5× 1.5k 2.1× 100 0.3× 117 0.4× 75 2.6k
Dong Zhou United States 26 564 0.4× 426 0.4× 862 1.2× 76 0.2× 21 0.1× 78 2.0k
Joachim Rudolph United States 27 1.1k 0.8× 515 0.5× 1.6k 2.3× 140 0.4× 201 0.8× 61 3.0k
Rogier C. Buijsman Netherlands 20 249 0.2× 230 0.2× 566 0.8× 32 0.1× 173 0.7× 49 1.3k
Wenhua Chu United States 26 430 0.3× 332 0.3× 1.1k 1.6× 81 0.2× 25 0.1× 51 1.9k

Countries citing papers authored by Aaron Balog

Since Specialization
Citations

This map shows the geographic impact of Aaron Balog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Balog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Balog more than expected).

Fields of papers citing papers by Aaron Balog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Balog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Balog. The network helps show where Aaron Balog may publish in the future.

Co-authorship network of co-authors of Aaron Balog

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Balog. A scholar is included among the top collaborators of Aaron Balog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Balog. Aaron Balog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velaparthi, Upender, Mark G. Saulnier, David B. Frennesson, et al.. (2022). The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer. Bioorganic & Medicinal Chemistry Letters. 75. 128951–128951. 7 indexed citations
2.
Discenza, Lorell, Aaron Balog, Christine Huang, et al.. (2022). Quantification of Linrodostat and its metabolites: Overcoming bioanalytical challenges in support of a discovery Indoleamine 2,3 dioxygenase program. Journal of Chromatography B. 1207. 123305–123305. 2 indexed citations
3.
Wagner, Nicole D., Jing Yan, Jing Li, et al.. (2021). Native mass spectrometry and gas-phase fragmentation provide rapid and in-depth topological characterization of a PROTAC ternary complex. Cell chemical biology. 28(10). 1528–1538.e4. 20 indexed citations
4.
Balog, Aaron, et al.. (2020). Preclinical Characterization of Linrodostat Mesylate, a Novel, Potent, and Selective Oral Indoleamine 2,3-Dioxygenase 1 Inhibitor. Molecular Cancer Therapeutics. 20(3). 467–476. 37 indexed citations
5.
Nelp, Micah T., John T. Hunt, John A. Newitt, et al.. (2018). Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form. Proceedings of the National Academy of Sciences. 115(13). 3249–3254. 140 indexed citations
6.
Williams, David, Jay A. Markwalder, Aaron Balog, et al.. (2018). Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(4). 732–736. 15 indexed citations
7.
Tian, Yuan, et al.. (2013). Synthesis of [3α‐3H] 17α‐Hydroxy pregnenolone and [3α‐3H] Pregnenolone. Journal of Labelled Compounds and Radiopharmaceuticals. 57(1). 1–11. 1 indexed citations
8.
Campagnaro, Erica, Aaron Balog, David R. Kaplan, et al.. (2011). Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance. Bone Marrow Transplantation. 47(9). 1212–1216. 17 indexed citations
9.
Foster, William R., Bruce D. Car, Hong Shi, et al.. (2010). Drug safety is a barrier to the discovery and development of new androgen receptor antagonists. The Prostate. 71(5). 480–488. 92 indexed citations
10.
Attar, Ricardo M., Maria Jure–Kunkel, Aaron Balog, et al.. (2009). Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer. Cancer Research. 69(16). 6522–6530. 38 indexed citations
11.
Salvati, Mark, Aaron Balog, Weifang Shan, et al.. (2008). Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 1910–1915. 20 indexed citations
12.
Balog, Aaron, Mark Salvati, Weifang Shan, et al.. (2004). The synthesis and evaluation of [2.2.1]-bicycloazahydantoins as androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(24). 6107–6111. 25 indexed citations
13.
Salvati, Mark, Aaron Balog, Donna Wei, et al.. (2004). Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus. Bioorganic & Medicinal Chemistry Letters. 15(2). 389–393. 33 indexed citations
14.
Salvati, Mark, Aaron Balog, Weifang Shan, et al.. (2004). Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(2). 271–276. 48 indexed citations
15.
16.
Sepp‐Lorenzino, Laura, et al.. (1999). The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells. Prostate Cancer and Prostatic Diseases. 2(1). 41–52. 30 indexed citations
17.
Balog, Aaron, Christina R. Harris, Kenneth A. Savin, et al.. (1998). A Novel Aldol Condensation with 2-Methyl-4-pentenal and Its Application to an Improved Total Synthesis of Epothilone B. Angewandte Chemie International Edition. 37(19). 2675–2678. 61 indexed citations
18.
Balog, Aaron, Christina R. Harris, Kenneth A. Savin, et al.. (1998). Eine neuartige Aldolkondensation mit 2-Methyl-4-pentenal und ihr Einsatz in einer verbesserten Totalsynthese von Epothilon B. Angewandte Chemie. 110(19). 2821–2824. 21 indexed citations
19.
Cass, Quézia B., et al.. (1997). Enantiomeric resolution by HPLC of axial chiral amides using amylose tris[(S)-1-phenylethylcarbamate]. Chirality. 9(2). 109–112. 24 indexed citations
20.
Balog, Aaron, Dong‐Fang Meng, Peter Bertinato, et al.. (1997). Struktur‐Wirkungs‐Beziehungen der Epothilone und erster In‐vivo‐Vergleich mit Paclitaxel. Angewandte Chemie. 109(19). 2178–2181. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquı́n Pastor Breakdown of academic impact, for papers by R. M. Borzilleri Breakdown of academic impact, for papers by Andrew J. Souers Breakdown of academic impact, for papers by Karima Bettayeb Breakdown of academic impact, for papers by Jen‐Shin Song Breakdown of academic impact, for papers by Thelma S. Angeles Breakdown of academic impact, for papers by Dong Zhou Breakdown of academic impact, for papers by Joachim Rudolph Breakdown of academic impact, for papers by Rogier C. Buijsman Breakdown of academic impact, for papers by Wenhua Chu
Rankless by CCL
2026